Table 5.
Expression variations (FSH + PP) vs PP Level of significance p < 0.01
| hFSH + PP vs. PP | ||||
|---|---|---|---|---|
| ALDH2 | 1,74E-03 | 1.69 | Up | Aldehyde dehydrogenase 2 family (mitochondrial) |
| RAC1 | 6,58E-03 | 1.68 | Up | Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
| PRKAR2B | 1,06E-03 | 1.67 | Up | Protein kinase, cAMP-dependent. Regulation of cAMP signalling |
| ADD3 | 9,51E-03 | 1.65 | Up | Adducin 3 (gamma) |
| SSBP2 | 8,98E-03 | 1.62 | Up | Single-stranded DNA binding protein 2 |
| SMARCA1 | 8,78E-03 | 1.58 | Up | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
| SUZ12 | 8,90E-03 | 1.55 | Up | Suppressor of zeste 12 homolog (Drosophila) |
| LOC572558 | 7,37E-04 | 1.51 | Up | Hypothetical locus LOC572558 |
| RBP1 | 5,21E-03 | 1.51 | Up | retinol binding protein 1, cellular |
| ANP32A | 4,59E-03 | 1.50 | Up | Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
| ATP5A1 | 1,89E-03 | 1.50 | Up | ATP synthase, H + transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
| AKAP2 | 9,89E-05 | 2.43 | Down | A kinase (PRKA) anchor protein 2 |
| CYP51A1 | 1,25E-03 | 2.02 | Down | Cytochrome P450, family 51, subfamily A, polypeptide 1 |
| GRK5 | 3,15E-03 | 1.85 | Down | G protein-coupled receptor kinase 5 |
| TET3 | 4,51E-03 | 1.80 | Down | Tet oncogene family member 3 |
| MLLT3 | 5,38E-03 | 1.76 | Down | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
| WSB2 | 8,36E-04 | 1.67 | Down | WD repeat and SOCS box-containing 2 |
| TM4SF1 | 3,12E-03 | 1.65 | Down | Transmembrane 4 L six family member 1 |
The following genes AK3L1,FOSB, NAP1L1, EGR3,ESD,ZnF664,TMEM97,CRTAP,BNIP3,VSP41,FKBP11,NCOA4, TPI1 and EIF4E2 are up regulated at 0.05 < p < 0.01
IL8 and TM4SF1 genes are down regulated at 0.05 < p < 0.01